Curatis Holding AG (SWX:CURN)

Switzerland flag Switzerland · Delayed Price · Currency is CHF
11.55
-0.65 (-5.33%)
Last updated: Jun 4, 2025
69.85%
Market Cap 58.16M
Revenue n/a
Net Income n/a
Shares Out 4.99M
EPS n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 3,851
Open 11.50
Previous Close 12.20
Day's Range 11.50 - 11.55
52-Week Range 5.00 - 18.20
Beta n/a
RSI 53.13
Earnings Date n/a

About Curatis Holding AG

Curatis Holding AG engages in the acquisition, development, and commercialization of medicines for the prevention, diagnosis, and treatment of rare and specialty care diseases. It offers its products in the areas of antiplatelet, metastatic hormone receptor-positive breast cancer, anti-arrhythmic, nasal oil, wilson’s disease, cyanide poisoning, digoxin toxicity, antihypotensive, bladder pain syndrome/intersticial cystitis, antibioticum, diagnostic ophthalmology, antiviral, ophtalmic/ antibioticum, gentamycin collagen sponge, benign prostatic hy... [Read more]

Sector Healthcare
CEO Roland Rutschmann
Employees 7
Stock Exchange SIX Swiss Exchange
Ticker Symbol CURN
Full Company Profile

News

There is no news available yet.